Fozivudine tidoxil
促销价¥{{model.attbuying.price}}
市场价¥0.00
累计销量0 累计评价0 人评论
-
{{item.title}}
| 包装规格: | 1mg 5mg 25mg 50mg 100mg in glass bottle |
| 产品描述: | 基本信息 产品编号:F10314 产品名称:Fozivudine tidoxil CAS: 141790-23-0 储存条件 粉末 -20℃ 四年 分子式: C35H64N5O8PS 分子量 745.95 化学名: [(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl (2-decoxy-3-dodecylsulfanylpropyl) hydrogen phosphate Solubility (25°C) 体外 DMSO Ethanol Water 体内 现配现用 <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 生物活性 产品描述 一种有口服活性的硫醚脂质-齐多夫定 (lipid-zidovudine) 偶联物,具有抗 HIV 活性。 靶点/IC50 HIV 体外研究 Fozivudine tidoxil (BM-211290) is a member of the nucleoside analogue reverse transcriptase inhibitor (NRTI) family. 体内研究 Fozivudine tidoxil (BM-211290; 45 mg/kg; PO; twice daily; one day before FIV challenge for a total of six weeks) is effective atlowering plasma- and cell-associated viremia at two weeks post-FIV infection. Animal Mode: Specific pathogen-free cats at 6 months of age Dosage: 45mg/kg Administration: PO; twice daily; one day before FIV challenge for a total of six weeks Result: Effective at lowering plasma- and cell-associated viremia at two weeks post-feline immunodeficiency virus (FIV) infection with a trend toward lower plasma- andcellassociated viremia at four and six weeks post-infection (PI). |
| 保存条件: | -20℃ |
-
蜀牛玻璃三角瓶
¥85.00 销量:16
-
15mL锥底离心管,袋装灭菌,橙色盖
¥636.00 销量:12
-
UFC5030BK 超滤管[0.5ml 30KD]
¥52.00 销量:10
-
UFC5010BK 超滤管[0.5ml 10KD]
¥52.00 销量:10
-
20×TBST缓冲液
¥130.00 销量:10
-
10mL移液管,易撕型全塑包装
¥456.00 销量:10
-
¥158.00
通用型 DNA 纯化回收试剂盒 -
¥158.00
质粒快速小提试剂盒 -
¥828.00
100mm TC细胞培养皿,袋装灭菌

